US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Nightingale Health Oyj (QX) (NGHLF) 銘柄情報

Nightingale Health Oyj (QX) (NGHLF)

1.19

0.00

(0.00%)

終了 6月27日 5:00AM

Nightingale Health Oyj (QX) (NGHLF) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

1.19

( - )

買値

0.0013

売値

329,000.94

出来高

-

0.00 日の範囲 0.00

1.19 52 週間の範囲 1.75

時価総額

前日終値

1.19

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 311,454

発行済株式数

60,360,995

配当利回り

PER

-2.53

1 株当たり利益 (EPS)

-0.32

歳入

4.8M

純利益

-19.07M

Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company’s Health Check that detects the risks associated with various common chronic diseases from ... Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company’s Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely. It also offers blood analysis, self collection kits, urine analysis, and biomarkers services. It provides its services to research programs, universities, and healthcare providers. Nightingale Health Oyj was incorporated in 2002 and is headquartered in Helsinki, Finland. 詳細を表示

セクター

Healthcare

業界

Medical Diagnostics & Screening

ウェブサイト

nightingalehealth.com

本社

Helsinki, Finland

設立

2026

Nightingale Health Oyj (QX) is listed in the Healthcare sector of the その他OTC with ticker NGHLF. The last closing price for Nightingale Health Oyj (QX) was US$1.19. Over the last year, Nightingale Health Oyj (QX) shares have traded in a share price range of US$ 1.19 to US$ 1.75.

Nightingale Health Oyj (QX) currently has 60,360,995 shares in issue. The market capitalisation of Nightingale Health Oyj (QX) is US$71.83 million. Nightingale Health Oyj (QX) has a price to earnings ratio (PE ratio) of -2.53.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	-0.56	-32	1.75	1.75	1.19	40	1.265	CS
26	-0.56	-32	1.75	1.75	1.19	25	1.265	CS
52	-0.56	-32	1.75	1.75	1.19	10	1.265	CS
156	-0.56	-32	1.75	1.75	1.19	130	1.72025452	CS
260	-0.56	-32	1.75	1.75	1.19	130	1.72025452	CS

NGHLF - Frequently Asked Questions (FAQ)

What is the current Nightingale Health Oyj (QX) share price?

The current share price of Nightingale Health Oyj (QX) is US$ 1.19

How many Nightingale Health Oyj (QX) shares are in issue?

Nightingale Health Oyj (QX) has 60,360,995 shares in issue

What is the market cap of Nightingale Health Oyj (QX)?

The market capitalisation of Nightingale Health Oyj (QX) is USD 71.83M

What is the 1 year trading range for Nightingale Health Oyj (QX) share price?

Nightingale Health Oyj (QX) has traded in the range of US$ 1.19 to US$ 1.75 during the past year

What is the PE ratio of Nightingale Health Oyj (QX)?

The price to earnings ratio of Nightingale Health Oyj (QX) is -2.53

What is the cash to sales ratio of Nightingale Health Oyj (QX)?

The cash to sales ratio of Nightingale Health Oyj (QX) is 10.05

What is the registered address of Nightingale Health Oyj (QX)?

The registered address for Nightingale Health Oyj (QX) is Mannerheimintie 164a, Helsinki, Uusimaa, 00300

What is the Nightingale Health Oyj (QX) website address?

The website address for Nightingale Health Oyj (QX) is nightingalehealth.com

Which industry sector does Nightingale Health Oyj (QX) operate in?

Nightingale Health Oyj (QX) operates in the Medical Diagnostics & Screening sector

RocketingEnchanter97

RocketingEnchanter97 5分前

This ended up being a dud

holter49

holter49 5分前

No reason to be negative with such great activity happening with NPHC.

12yearplan

12yearplan 6分前

Heard these criticisms which are all victim of the same fault - the human stops prompting and correcting. So lame to lay the blame and so inane and what a shame - just keep going with the prompts and refinement!. - you will get your answer and more - carve outt new territory!.

joe botts

joe botts 8分前

Its hysterical!

DMC8

https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amrn/amarin/valuation
https://investorshub.advfn.com/uimage/uploads/2026/6/26/lthqtIMG_4710.jpeg

ysung

Does the tweet imply that Co is now submitting audited fins to FINRA ???

Taleb Spinoza

Taleb Spinoza 16分前

Have a good weekend y’all. The sunny day will come.
https://youtu.be/aLmTyBXOJOg?is=TfM_l-9y2kvfxZg-

Kjv

I miss them though😂 but you are right! As soon as the run starts, they will be here in droves! We need this board to be more fun 😂

November61

November61 22分前

102,113,146 shares trade at the close, making the daily above 171 millions, well above the daily average.

Just Food for thought.
Sometime might finally happen with that P & D.

WHITTENHALLJR

WHITTENHALLJR 25分前

Some for me … I know we’ll be at .02 soon … no fear to by up

ExtremelyBullishZig

ExtremelyBullishZig 25分前

Right!
Principal and Chief are the same thing.

meirluc

meirluc 26分前

"If approval does depend on the build-out of the C suite
But even if the answer to the question is "NO" is it not also possible that they have determined to wait for the completion of the C suite before approval - EVEN IF NOT REQUIRED? (perhaps to simplify or eliminate future regulatory actio

learningcurve2020

learningcurve2020 26分前

Those financiers need a reverse split to make it profitable again solely for physiological reasons.

watcher777

watcher777 28分前

I've spent so much time researching this company and have met with the CEO, CFO and also shook professor Li's hand and at this point I have no trust in any of their ability to be transparent. However, they may very well do great things but I don't think they have us in mind.

MrBobbob

MrBobbob 28分前

Ronnie Replay

Ronnie Replay 30分前

Wonder how Hi_Lo is feeling right now lol.

12yearplan

12yearplan 31分前

Would fit a common pattern.

Southern Gal

Southern Gal 31分前

looking strong again

Dragonman1

Dragonman1 33分前

Bashers are hard at Work trying to destroy stocks!

joe botts

joe botts 33分前

Wow!!!! Howd you know? Spot on, geez what a genius! Oh no NOW what do I do? Lmao!!!!

Dragonman1

Dragonman1 35分前

Don' sell that is your answer!

High_Desert

High_Desert 37分前

Hi, new guy here, bought some TGLO a few years ago. What is the realistic upside value of this stock in say 5-7 years if things go right? I know, impossible to accurately answer, but just any thoughts if you have them.

waterchaser

waterchaser 37分前

Thank you satter for keeping us up-to-date…
on HIRU’s legal messes.
I don’t have the ability (or maybe acumen) to offer what you do.
Kudos.
.

88TH MAN

88TH MAN 38分前

Maybe we should let a jury decide that? BULLISH!!!

Nightingale Health Oyj (QX)

Centaurus Metals

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。